Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

The Addition of Lenalidomide to R-CHOP Is Effective for Prevention of CNS Relapse in High-Risk Patients with Diffuse Large B-Cell Lymphoma

Xiaolei Wei, Xutao Guo, Qi Wei, Dan Xiong, Peng Zhang, Zewen Zhang, Yongqiang Wei, Ru Feng

Blood (2024) 144 (Supplement 1): 1740.

https://doi.org/10.1182/blood-2024-204915

Published: 2024

Journal Articles

Lbl-034, a Highly Differentiated T-Cell Engaging Bispecific Antibody Targeting GPRC5D for the Treatment of Relapsed or Refractory Multiple Myeloma

Baohui Wang, Xiao Huang, Jianming Sun, Yurong Qin, Hongyan Shang, Tingting Li, Guojin Wu, Min Chen, Hailin Wang, Peng Zhang, Duqing Jiang, Tongjun Liu, Mi Ye, Shengli Cai, Shoupeng Lai, Xiaoqiang Kang, Hong Ling

Blood (2023) 142 (Supplement 1): 4672.

https://doi.org/10.1182/blood-2023-181395

Published: 2023

Journal Articles

The Addition of Lenalidomide to R-CHOP Is Effective for Prevention of CNS Relapse in High-Risk Patients with Diffuse Large B-Cell Lymphoma

Xiaolei Wei, Xutao Guo, Qi Wei, Dan Xiong, Peng Zhang, Zewen Zhang, Yongqiang Wei, Ru Feng

Blood (2023) 142 (Supplement 1): 6223.

https://doi.org/10.1182/blood-2023-182496

Published: 2023

Journal Articles

Analysis of Perioperative Factor Replacement Therapy for Hemophilia

Hu Zhou, Bingjie Ding, Peng Zhang, Mengjuan Li, Xuewen Song

Blood (2023) 142 (Supplement 1): 5472.

https://doi.org/10.1182/blood-2023-173816

Published: 2023

Journal Articles

Mutational Landscape of Relapsed or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma in Chinese Patients

Li-Min Gao, Wei-Ping Liu, Sha Zhao, Yuan Zhang, Peng Zhang, Jiqiang He, Qin Fu, Kai Wang, Fei Pang

Blood (2019) 134 (Supplement_1): 5273.

https://doi.org/10.1182/blood-2019-125438

Published: 2019

Journal Articles

Cooperative Epigenetic Regulation By ASXL1 and NF1 Loss on Leukemogenesis

Peng Zhang, PhD, Fuhong He, PhD, Jie Bai, MD, Shi Chen, Stephen D. Nimer, MD, Yuan Zhou, PhD, Mingjiang Xu, MD PhD, Qianfei Wang, PhD, Feng-Chun Yang, MD PhD

Blood (2018) 132 (Supplement 1): 652.

https://doi.org/10.1182/blood-2018-99-110964

Published: 2018

Journal Articles

TBK1/Ikkε Inhibitor Amlx Blocks Multiple Myeloma Cell Growth in Vitro and In Vivo

Quanhong Sun, PhD, Peng Zhang, PhDMD, Juraj Adamik, PhD, Konstantinos Lontos, MD, Valentina Marchica, MS, Nicola Giuliani, MD PhD, Rebecca W. Silbermann, MD, G. David Roodman, MD PhD, Deborah Lynn Galson, PhD

Blood (2018) 132 (Supplement 1): 4504.

https://doi.org/10.1182/blood-2018-99-119677

Published: 2018

Journal Articles

Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies

Blood (2018) 131 (3): 328–341.

https://doi.org/10.1182/blood-2017-06-789669

Published: 2018

Includes: Supplemental data

Journal Articles

Loss of ASXL1 in the Bone Marrow Niche Dysregulates Hematopoietic Stem Cell Fates through RNA Polymerase II Complex

Peng Zhang, PhD, Zizhen Chen, PhD, Rong Li, PhD, Ying Guo, MD PhD, Mingjiang Xu, MDPhD, Yuan Zhou, PhD, Feng-Chun Yang, MD PhD

Blood (2017) 130 (Supplement 1): 133.

https://doi.org/10.1182/blood.V130.Suppl_1.133.133

Published: 2017

Journal Articles

Gain-of-Function of ASXL1 Truncating Protein in the Pathogenesis of Myeloid Malignancies

Hui Yang, PhD, Stefan Kurtenbach, PhD, Ying Guo, MD PhD, Ines Lohse, PhD, Michael Durante, PhD candidate, Peng Zhang, PhD, Yuan Zhou, PhD, William Harbour, MDPhD, Claes Wahlestedt, Mingjiang Xu, MDPhD, Feng-Chun Yang, MD PhD

Blood (2017) 130 (Supplement 1): 564.

https://doi.org/10.1182/blood.V130.Suppl_1.564.564

Published: 2017

Journal Articles

ASXL2 Is Required for Normal Hematopoiesis and Loss of a sxl2 Leads to Myeloid Malignancies in Mice

Jianping Li, Fuhong He, PhD, Peng Zhang, PhD, Shi Chen, MD PhD, Hui Shi, Yanling Sun, Guo Ying, Hui Yang, Stephen D. Nimer, MD, Qian-Fei Wang, Mingjiang Xu, MD PhD, Feng-Chun Yang, MD PhD

Blood (2016) 128 (22): 1509.

https://doi.org/10.1182/blood.V128.22.1509.1509

Published: 2016

Journal Articles

EZH2 Inhibitor GSK126 Exhibits Osteo-Anabolic Properties in MM Bone Disease and Synergizes with Bortezomib to Inhibit MM Cell Viability

Juraj Adamik, PhD, Rebecca Silbermann, MD, Konstantinos Lontos, MD, Peng Zhang, PhD, Quanhong Sun, Deborah Lynn Galson, PhD, G. David Roodman, MD PhD

Blood (2016) 128 (22): 3247.

https://doi.org/10.1182/blood.V128.22.3247.3247

Published: 2016

Journal Articles

LIM-Domain Protein Ajuba Is a Required Co-Factor for Gfi1-Induced Epigenetic Switch Regulating Runx2 Repression in Multiple Myeloma-Exposed Pre-Osteoblasts

Juraj Adamik, PhD, Jixin Ding, PhD, Wei Zhao, Peng Zhang, PhD, Quanhong Sun, G. David Roodman, MD PhD, Deborah Lynn Galson, PhD

Blood (2015) 126 (23): 4216.

https://doi.org/10.1182/blood.V126.23.4216.4216

Published: 2015

Journal Articles

Cooperative Effect of Haploinsufficient ASXL1 and NF1 in Acute Myeloid Leukemia Transformation

Peng Zhang, PhD, Shohei Yamamoto, MD PhD, Shi Chen, MD PhD, Yuan Zhou, PhD, Mingjiang Xu, MD PhD, Feng-Chun Yang, MD PhD

Blood (2015) 126 (23): 1224.

https://doi.org/10.1182/blood.V126.23.1224.1224

Published: 2015

Journal Articles

ASXL1 Is a Key Regulator for Erythroid Development and Asxl1 Loss Impairs Erythropoiesis In Vivo

Shohei Yamamoto, MD PhD, Hui Shi, MD PhD, Shi Chen, MD PhD, Peng Zhang, PhD, Yuan Zhou, PhD, Mingjiang Xu, MD PhD, Feng-Chun Yang, MD PhD

Blood (2015) 126 (23): 3644.

https://doi.org/10.1182/blood.V126.23.3644.3644

Published: 2015

Journal Articles

PML4 facilitates erythroid differentiation by enhancing the transcriptional activity of GATA-1

Jie Wu, Li-Quan Zhou, Wei Yu, Zhi-Guo Zhao, Xue-Min Xie, Wen-Tian Wang, Jian Xiong, Man Li, Zheng Xue, Xing Wang, Peng Zhang, Bei-Bei Mao, De-Long Hao, Xiang Lv, De-Pei Liu

Blood (2014) 123 (2): 261–270.

https://doi.org/10.1182/blood-2013-02-483289

Published: 2014

Includes: Supplemental data

Journal Articles

An acute negative bystander effect of γ-irradiated recipients on transplanted hematopoietic stem cells

Hongmei Shen, Hui Yu, Paulina H. Liang, Haizi Cheng, Richard XuFeng, Youzhong Yuan, Peng Zhang, Clayton A. Smith, Tao Cheng

Blood (2012) 119 (15): 3629–3637.

https://doi.org/10.1182/blood-2011-08-373621

Published: 2012

Includes: Supplemental data

Journal Articles

Synthetic Oligonucleotide Aptamer (a revolutionary antibody?) for Lymphoma Diagnosis

Zihua Zeng, MD, Peng Zhang, MD, PhD., Youli Zu, MD, PhD

Blood (2011) 118 (21): 772.

https://doi.org/10.1182/blood.V118.21.772.772

Published: 2011

Journal Articles

Expression of FLT3 Internal Tandem Duplication in Pediatric Patients with Acute Myeloid Leukemia and Its Correlation with Multidrug Resistance.

Zhenhua Qiao, MD, Jiangning Zhao, Lianrong Xu, Quanyi Lu, Xiaoqing Niu, Peng Zhang, Zhao Wang

Blood (2009) 114 (22): 4427.

https://doi.org/10.1182/blood.V114.22.4427.4427

Published: 2009

Journal Articles

Haplo-Identical Allogeneic Stem Cell Transplantation Using GCSF-Mobilized Marrow Plus Blood Stem Cells from Parent Donors for Children with High-Risk Leukemia.

Quanyi Lu, MD, PhD, Xiaoqing Niu, MD, Peng Zhang, MD, Delong Liu, MD, PHD

Blood (2007) 110 (11): 5084.

https://doi.org/10.1182/blood.V110.11.5084.5084

Published: 2007

NARROW

The Addition of Lenalidomide to R-CHOP Is Effective for Prevention of CNS Relapse in High-Risk Patients with Diffuse Large B-Cell Lymphoma

Lbl-034, a Highly Differentiated T-Cell Engaging Bispecific Antibody Targeting GPRC5D for the Treatment of Relapsed or Refractory Multiple Myeloma

The Addition of Lenalidomide to R-CHOP Is Effective for Prevention of CNS Relapse in High-Risk Patients with Diffuse Large B-Cell Lymphoma

Analysis of Perioperative Factor Replacement Therapy for Hemophilia

Mutational Landscape of Relapsed or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma in Chinese Patients

Cooperative Epigenetic Regulation By ASXL1 and NF1 Loss on Leukemogenesis

TBK1/Ikkε Inhibitor Amlx Blocks Multiple Myeloma Cell Growth in Vitro and In Vivo

Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies

Loss of ASXL1 in the Bone Marrow Niche Dysregulates Hematopoietic Stem Cell Fates through RNA Polymerase II Complex

Gain-of-Function of ASXL1 Truncating Protein in the Pathogenesis of Myeloid Malignancies

ASXL2 Is Required for Normal Hematopoiesis and Loss of a sxl2 Leads to Myeloid Malignancies in Mice

EZH2 Inhibitor GSK126 Exhibits Osteo-Anabolic Properties in MM Bone Disease and Synergizes with Bortezomib to Inhibit MM Cell Viability

LIM-Domain Protein Ajuba Is a Required Co-Factor for Gfi1-Induced Epigenetic Switch Regulating Runx2 Repression in Multiple Myeloma-Exposed Pre-Osteoblasts

Cooperative Effect of Haploinsufficient ASXL1 and NF1 in Acute Myeloid Leukemia Transformation

ASXL1 Is a Key Regulator for Erythroid Development and Asxl1 Loss Impairs Erythropoiesis In Vivo

PML4 facilitates erythroid differentiation by enhancing the transcriptional activity of GATA-1

An acute negative bystander effect of γ-irradiated recipients on transplanted hematopoietic stem cells

Synthetic Oligonucleotide Aptamer (a revolutionary antibody?) for Lymphoma Diagnosis

Expression of FLT3 Internal Tandem Duplication in Pediatric Patients with Acute Myeloid Leukemia and Its Correlation with Multidrug Resistance.

Haplo-Identical Allogeneic Stem Cell Transplantation Using GCSF-Mobilized Marrow Plus Blood Stem Cells from Parent Donors for Children with High-Risk Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only